🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the producers of Tylenol, claiming the corporations hid potential risks that the drug presented to pediatric neurological development.

The court filing follows four weeks after President Donald Trump publicized an unverified association between consuming Tylenol - alternatively called paracetamol - during pregnancy and autism in offspring.

The attorney general is taking legal action against Johnson & Johnson, which formerly manufactured the drug, the only pain reliever suggested for expectant mothers, and the current manufacturer, which currently produces it.

In a declaration, he stated they "deceived the public by making money from discomfort and pushing pills regardless of the potential hazards."

Kenvue asserts there is no credible evidence tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, intentionally threatening countless individuals to line their pockets," the attorney general, from the Republican party, said.

The manufacturer stated officially that it was "deeply concerned by the spread of false claims on the security of paracetamol and the likely effects that could have on the welfare of American women and children."

On its website, Kenvue also mentioned it had "consistently assessed the relevant science and there is insufficient valid information that demonstrates a verified association between consuming acetaminophen and autism."

Associations representing doctors and health professionals agree.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the main ingredient in Tylenol - is among limited choices for women during pregnancy to treat discomfort and elevated temperature, which can create significant medical dangers if left untreated.

"In over twenty years of investigation on the consumption of acetaminophen in pregnancy, no reliable research has conclusively proven that the usage of paracetamol in any period of pregnancy causes neurodevelopmental disorders in young ones," the group said.

This legal action cites latest statements from the previous government in arguing the medication is allegedly unsafe.

Last month, Trump raised alarms from health experts when he instructed women during pregnancy to "struggle intensely" not to take acetaminophen when ill.

The US Food and Drug Administration then published an announcement that doctors should consider limiting the usage of Tylenol, while also mentioning that "a proven link" between the medication and autism in minors has not been proven.

Health Secretary RFK Jr, who supervises the FDA, had vowed in April to undertake "a massive testing and research effort" that would determine the cause of autism spectrum disorder in a limited time.

But specialists advised that identifying a single cause of autism - believed by scientists to be the outcome of a complicated interplay of genetic and surrounding conditions - would be difficult.

Autism is a form of lifelong neurodivergence and disability that affects how persons perceive and engage with the world, and is identified using doctors' observations.

In his court filing, the attorney general - a Trump ally who is running for federal office - asserts Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around acetaminophen and autism.

The case attempts to require the companies "remove any commercial messaging" that states Tylenol is secure for pregnant women.

The court case parallels the grievances of a assembly of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in recently.

The court threw out the legal action, stating studies from the family's specialists was inconclusive.